AU2001294744A1 - Dsp-16 dual-specificity phosphatase - Google Patents

Dsp-16 dual-specificity phosphatase

Info

Publication number
AU2001294744A1
AU2001294744A1 AU2001294744A AU9474401A AU2001294744A1 AU 2001294744 A1 AU2001294744 A1 AU 2001294744A1 AU 2001294744 A AU2001294744 A AU 2001294744A AU 9474401 A AU9474401 A AU 9474401A AU 2001294744 A1 AU2001294744 A1 AU 2001294744A1
Authority
AU
Australia
Prior art keywords
dsp
dual
specificity phosphatase
phosphatase
specificity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294744A
Inventor
Ralf M. Luche
Bo Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceptyr Inc
Original Assignee
Ceptyr Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceptyr Inc filed Critical Ceptyr Inc
Publication of AU2001294744A1 publication Critical patent/AU2001294744A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
AU2001294744A 2000-09-26 2001-09-25 Dsp-16 dual-specificity phosphatase Abandoned AU2001294744A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23548700P 2000-09-26 2000-09-26
US60/235,487 2000-09-26
PCT/US2001/030124 WO2002026997A2 (en) 2000-09-26 2001-09-25 Dsp-16 dual-specificity phosphatase

Publications (1)

Publication Number Publication Date
AU2001294744A1 true AU2001294744A1 (en) 2002-04-08

Family

ID=22885707

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294744A Abandoned AU2001294744A1 (en) 2000-09-26 2001-09-25 Dsp-16 dual-specificity phosphatase

Country Status (3)

Country Link
US (1) US20020137170A1 (en)
AU (1) AU2001294744A1 (en)
WO (1) WO2002026997A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005506040A (en) 2000-12-20 2005-03-03 ブリストル−マイヤーズ　スクイブ　カンパニー Polynucleotide encoding a novel human phosphatase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2003509053A (en) * 1999-09-15 2003-03-11 インサイト・ゲノミックス・インコーポレイテッド Protein phosphatase and protein kinase
WO2001046394A2 (en) * 1999-12-21 2001-06-28 Sugen, Inc. Mammalian protein phosphatases
US20020065406A1 (en) * 2000-03-24 2002-05-30 Meyers Rachel A. 18221, a novel dual specificity phosphatase and uses thereof
AU3605901A (en) * 2000-03-07 2001-09-17 Chiba Prefecture Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma
JP2001245671A (en) * 2000-03-07 2001-09-11 Chiba Prefecture New gene cloned in human neuroblastoma and fragment thereof
WO2001077340A1 (en) * 2000-04-10 2001-10-18 Merck Patent Gmbh Identification of a dual specificity phosphatase: dusp-10
JP2004528805A (en) * 2000-07-28 2004-09-24 インサイト・ゲノミックス・インコーポレイテッド Protein phosphatase

Also Published As

Publication number Publication date
US20020137170A1 (en) 2002-09-26
WO2002026997A2 (en) 2002-04-04
WO2002026997A3 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
AU2002230562A1 (en) Positive-return gambling
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001258784A1 (en) Tyrosine phosphatase inhibitors
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2002222571A1 (en) Balancer
AU2001258924A1 (en) Microsatellite-aflp
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001238048A1 (en) Mammalian sphingosine-1-phosphate phosphatase
AU6355700A (en) Dsp-11 dual-specificity map kinase phosphatase
AU4658400A (en) Dsp-10 dual-specificity map kinsase phosphatase
AU2001246864A1 (en) Hypotensors
AU2001282644A1 (en) Case
AU2001278773A1 (en) Novel pla1
AU2001233026A1 (en) Phosphodiesterases
AU2001291146A1 (en) Dsp-15 dual-specificity phosphatase
AU2001282234A1 (en) CDC25 phosphatase inhibitors
AU2001293320A1 (en) Nebulizer
MXPA03000860A (en) Cdc25 phosphatase inhibitors.
AU4206700A (en) Dsp-3 dual-specificity phosphatase
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001294744A1 (en) Dsp-16 dual-specificity phosphatase
AU2001259337A1 (en) Dsp-14 dual-specificity phosphatase